SalvaRx Group Plc

SalvaRx Group Plc

Health CarePharmaceuticals & Biotechnology
  • Price (GBX)30.50
  • Today's Change0.00 / 0.00%
  • Shares traded5.68k
  • 1 Year change-14.08%
  • Beta0.2005
Data delayed at least 20 minutes, as of May 26 2017 14:46 BST.
More ▼

Key statistics

On Friday, SalvaRx Group Plc (SALV:LSE) closed at 30.50, 37.08% above the 52 week low of 22.25 set on Jul 15, 2016.
52-week range
22.25Jul 15 201641.25Feb 02 2017
Previous close30.50
Average volume13.37k
Shares outstanding36.47m
Free float6.15m
P/E (TTM)--
Market cap11.12m GBP
EPS (TTM)-0.0589 GBP
Data delayed at least 20 minutes, as of May 26 2017 14:46 BST.
More ▼

Investors Chronicle View

The last IC recommendation on SalvaRx Group Plc shares was Sell at 27.00 on 20 Sep 2013Read the full article
© Thomson Reuters Click for restrictions
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.
Markit Short Selling Activity © Markit. All rights reserved.
Although Markit has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of Markit on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.